{"id":"https://openalex.org/W2363556367","doi":null,"title":"Effect of Irbesartan on Plasma Endothelin-1 and Nitrogen Monoxide in Elderly Patients with Essential Hypertension","display_name":"Effect of Irbesartan on Plasma Endothelin-1 and Nitrogen Monoxide in Elderly Patients with Essential Hypertension","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2363556367","mag":"2363556367"},"language":"en","primary_location":{"id":"mag:2363556367","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTotal-DDYS2003S1023.htm","pdf_url":null,"source":{"id":"https://openalex.org/S4306541551","display_name":"\u4e2d\u56fd\u533b\u5e08\u6742\u5fd7","issn_l":"1008-1372","issn":["1008-1372"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yishi zazhi","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084786137","display_name":"Chen Yao-we","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chen Yao-we","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5084786137"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27833217,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.02019999921321869,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":1.0},{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.7680000066757202},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9909999966621399},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9369999766349792},{"id":"https://openalex.org/keywords/at1-receptor-antagonists","display_name":"AT1 receptor antagonists","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.998873233795166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7846764922142029},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6672772169113159},{"id":"https://openalex.org/C2777097880","wikidata":"https://www.wikidata.org/wiki/Q988405","display_name":"Essential hypertension","level":3,"score":0.5368699431419373},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.49758437275886536},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.4622916877269745},{"id":"https://openalex.org/C149601957","wikidata":"https://www.wikidata.org/wiki/Q390566","display_name":"Endothelin 1","level":3,"score":0.43080809712409973},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.36192816495895386},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35069647431373596},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08227911591529846}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2363556367","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTotal-DDYS2003S1023.htm","pdf_url":null,"source":{"id":"https://openalex.org/S4306541551","display_name":"\u4e2d\u56fd\u533b\u5e08\u6742\u5fd7","issn_l":"1008-1372","issn":["1008-1372"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo yishi zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2379417880","https://openalex.org/W2378775883","https://openalex.org/W2393943862","https://openalex.org/W2349417004","https://openalex.org/W2382010613","https://openalex.org/W1967659716","https://openalex.org/W2361391589","https://openalex.org/W2393686260","https://openalex.org/W2404071089","https://openalex.org/W2095567844"],"abstract_inverted_index":{"Objective":[0],"To":[1],"investigate":[2],"effect":[3],"of":[4,32,106,111,121,132,141,147,150,166,169,182,194],"Irbesartan":[5,62,122,133,142,188],"on":[6],"plasma":[7],"endothelin-1":[8],"(ET-1)":[9],"and":[10,34,51,75,80,98,118,137],"nitrogen":[11],"monoxide":[12],"(NO)":[13],"in":[14,152,171],"elderly":[15,195],"patients":[16,24,196],"with":[17,25,38,109,197],"moderate":[18,198],"to":[19,67,199],"severe":[20,200],"essential":[21,26,201],"hypertension.Methods":[22],"Forty":[23],"hypertension":[27],"who":[28],"were":[29,48,56,77],"\u226560":[30],"years":[31],"age":[33],"had":[35],"been":[36],"treated":[37],"two":[39],"or":[40,52],"more":[41],"antihypertensive":[42],"drugs":[43],"but":[44],"whose":[45,53],"systolic":[46],"pressure":[47,55],"\u2265160":[49],"mmHg":[50],"diastolic":[54],"\u2265100mmHg,entered":[57],"into":[58],"the":[59,92,191],"present":[60],"study.":[61],"150mg":[63],"daily":[64],"was":[65,95,100,114,128,156],"added":[66],"their":[68],"original":[69],"treatment":[70,93,112,153,172],"for":[71],"6":[72,81,104],"week.":[73],"ET-1":[74],"NO":[76,99,126],"measured":[78],"before":[79,117],"week":[82],"after":[83,103,119,139,160],"treatment.used":[84],"forty-two":[85],"healthy":[86],"adults":[87],"as":[88],"controls.":[89],"Results":[90],"In":[91],"group,ET-1":[94],"significantly":[96,101,179],"decreased":[97],"increased":[102],"weeks,addition":[105],"Irbesartan.As":[107],"compared":[108],"controls,ET-1":[110],"group":[113,154,173],"higher":[115,138,157],"both":[116],"addition":[120,140,146,161,165],"(":[123,134],"P":[124,135,144,163,185],"0.001),":[125],"level":[127],"lower":[129],"befer":[130],"additicn":[131],"=0.038)":[136],"(1.0,":[143,162],"0.001).After":[145,164],"Irbesartan,the":[148,167],"ratio":[149,168],"ET/NO":[151],"(2,2)":[155],"than":[158],"that":[159,181],"ET-1/NO":[170],"(1.0":[174,184],")":[175],"did":[176],"not":[177],"differ":[178],"from":[180],"controls":[183],"=0.819).":[186],"Conclusions":[187],"may":[189],"improve":[190],"endothelial":[192],"function":[193],"hypertension.":[202]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}